Innoterix Labs
Samuel Reichberg is a highly experienced medical professional, currently serving as Co-founder and Chief Medical Officer at Innoterix Labs since March 2023, focusing on infectious disease molecular diagnosis. With a longstanding career, Reichberg has held various leadership roles including Assistant Director of Laboratories at ODA Primary Health Care Center, CEO of Laboratory Assessment and Biotech Systems, and Director at Pandemic Response Lab. Notable prior positions include Associate Medical Director at North Shore University Hospital Laboratory, Professor at Hofstra University Northwell Health School of Medicine, and Director roles in laboratory settings such as CareMount Medical and Bellevue Hospital Center. Samuel Reichberg's educational background includes an MD from Universidad de Chile and advanced degrees in Clinical Pathology and Molecular Biophysics from Yale University.
This person is not in any teams
Innoterix Labs
Innoterix Labs is an esoteric reference laboratory focused on addressing some of the greatest challenges facing diagnostic providers and the physicians they support. With rapidly rising costs, falling reimbursement, and greater patient demand for fast, reliable, and affordable test results, there has never been a greater need to maximize value for all healthcare stakeholders. Innoterix’s investments in research and development of new diagnostic technologies, processes, and assays are helping to facilitate the evolution of laboratories towards supporting value-based reimbursement. We are committed to driving innovation in laboratory technology and process in our state-of-the-art laboratory with a focus on molecular microbiology (bacteriology, virology, mycology, parasitology), antibiotic resistance gene testing, and immunology.